2026/10/19 更新

お知らせ

 

写真a

ミトウ タカユキ
三藤 崇行
MITO TAKAYUKI
所属
医学研究院 基礎医学部門 助教
医学部 医学科(併任)
職名
助教
外部リンク

研究分野

  • ライフサイエンス / 実験動物学

  • ライフサイエンス / 病態医化学

  • ライフサイエンス / 細胞生物学

経歴

  • 九州大学 大学院医学研究院・細胞生理学分野 助教 

    2025年3月 - 現在

  • ヘルシンキ大学 医学部 研究員 

    2019年4月 - 2024年12月

研究テーマ・研究キーワード

  • 研究テーマ: オートファジー

    研究キーワード: オートファジー

    研究期間: 2025年

  • 研究テーマ: マイトファジー

    研究キーワード: マイトファジー

    研究期間: 2025年

  • 研究テーマ: ミトコンドリア

    研究キーワード: ミトコンドリア

    研究期間: 2025年

  • 研究テーマ: ミトコンドリア病

    研究キーワード: ミトコンドリア病

    研究期間: 2025年

  • 研究テーマ: 疾患モデルマウス

    研究キーワード: 疾患モデルマウス

    研究期間: 2025年

論文

  • BNIP3/NIX-dependent mitophagy: molecular mechanisms and physiological roles 査読 国際誌

    Ginevskaia, T; Mito, T; Inoue, K; Kanki, T

    JOURNAL OF BIOCHEMISTRY   180 ( 3 )   185 - 194   2026年6月   ( ISSN:0021-924X eISSN:1756-2651 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Mitochondria are essential for cellular metabolism and homeostasis, and their quality and quantity must therefore be tightly controlled. Mitophagy, a selective form of autophagy targeting mitochondria, contributes to this control by eliminating damaged or superfluous mitochondria. Among the known mitophagy pathways, BNIP3/NIX-dependent mitophagy has emerged as a key mechanism, particularly under hypoxic and metabolic stress. Recent studies have provided important insights into how BNIP3 and NIX are transcriptionally induced, post-translationally regulated, and functionally coupled to the core autophagy machinery. These studies have also clarified their roles in isolation membrane tethering, membrane elongation, and mitophagosome formation. Beyond its molecular basis, accumulating evidence indicates that BNIP3/NIX-dependent mitophagy contributes to mitochondrial homeostasis, redox balance, and cellular stress adaptation. This review summarizes recent progress in understanding the molecular mechanisms and physiological significance of BNIP3/NIX-dependent mitophagy.

    DOI: 10.1093/jb/mvag048

    Web of Science

    PubMed

  • PDK4 and nutrient responses explain muscle specific manifestation in mitochondrial disease. 査読 国際共著 国際誌

    Pradhan S, Mito T, Khan NA, Olander S, Zhaivoron A, McWilliams TG, Suomalainen A

    Clinical and translational medicine   15 ( 7 )   e70404   2025年7月   ( ISSN:2001-1326 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    <h4>Background</h4>Mitochondria elicit various metabolic stress responses, the roles of which in diseases are poorly understood. Here, we explore how different muscles of one individual-extraocular muscles (EOMs) and quadriceps femoris (QFs) muscles-respond to mitochondrial disease. The aim is to explain why EOMs atrophy early in the disease, unlike other muscles.<h4>Methods</h4>We used a mouse model for mitochondrial myopathy ("deletor"), which manifests progressive respiratory chain deficiency and human disease hallmarks in itsmuscles. Analyses included histology, ultrastructure, bulk and single-nuclear RNA-sequencing, metabolomics, and mitochondrial turnover assessed through in vivo mitophagy using transgenic mito-QC marker mice crossed to deletors.<h4>Results</h4>In mitochondrial muscle disease, large QFs upregulate glucose uptake that drives anabolic glycolytic one-carbon metabolism and mitochondrial integrated stress response. EOMs, however, react in an opposite manner, inhibiting glucose and pyruvate oxidation by activating PDK4, a pyruvate dehydrogenase kinase and inhibitor. Instead, EOMs upregulate acetyl-CoA synthesis and fatty-acid oxidation pathways, and accumulate lipids. In QFs, Pdk4 transcription is not induced.- Amino acid levels are increased in QFs but are low in EOMs suggesting their catabolic use for energy metabolism. Mitophagy is stalled in both muscle types, in the most affected fibers.<h4>Conclusions</h4>Our evidence indicates that different muscles respond differently to mitochondrial disease even in one individual. While large muscles switch to anabolic mode and glycolysis, EOMs actively inhibit glucose usage. They upregulate lipid oxidation pathway, a non-optimal fuel choice in mitochondrial myopathy, leading to lipid accumulation and possibly increased reliance on amino acid oxidation. We propose that these consequences of non-optimal nutrient responses lead to EOMatrophy and progressive external ophthalmoplegia in patients. Our evidence highlights the importance of PDK4 and aberrant nutrient signaling underlying muscle atrophies.

    DOI: 10.1002/ctm2.70404

    Web of Science

    PubMed

  • De novoserine biosynthesis is protective in mitochondrial disease 査読 国際誌

    Jackson C.B., Marmyleva A., Monteuuis G., Awadhpersad R., Mito T., Zamboni N., Tatsuta T., Vincent A.E., Wang L., Khan N.A., Langer T., Carroll C.J., Suomalainen A.

    Cell Reports   44 ( 5 )   115710 - 115710   2025年5月   ( ISSN:26391856 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Cell Reports  

    The importance of serine as a metabolic regulator is well known for tumors and is also gaining attention in degenerative diseases. Recent data indicate that de novo serine biosynthesis is an integral component of the metabolic response to mitochondrial disease, but the roles of the response have remained unknown. Here, we report that glucose-driven de novo serine biosynthesis maintains metabolic homeostasis in energetic stress. Pharmacological inhibition of the rate-limiting enzyme, phosphoglycerate dehydrogenase (PHGDH), aggravated mitochondrial muscle disease, suppressed oxidative phosphorylation and mitochondrial translation, altered whole-cell lipid profiles, and enhanced the mitochondrial integrated stress response (ISR<sup>mt</sup>) in vivo in skeletal muscle and in cultured cells. Our evidence indicates that de novo serine biosynthesis is essential to maintain mitochondrial respiration, redox balance, and cellular lipid homeostasis in skeletal muscle with mitochondrial dysfunction. Our evidence implies that interventions activating de novo serine synthesis may protect against mitochondrial failure in skeletal muscle.

    DOI: 10.1016/j.celrep.2025.115710

    Scopus

    PubMed

  • Ancestral allele of DNA polymerase gamma modifies antiviral tolerance 査読

    Kang Y., Hepojoki J., Maldonado R.S., Mito T., Terzioglu M., Manninen T., Kant R., Singh S., Othman A., Verma R., Uusimaa J., Wartiovaara K., Kareinen L., Zamboni N., Nyman T.A., Paetau A., Kipar A., Vapalahti O., Suomalainen A.

    Nature   628 ( 8009 )   844 - 853   2024年4月   ( ISSN:0028-0836 )

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Nature  

    <jats:title>Abstract</jats:title><jats:p>Mitochondria are critical modulators of antiviral tolerance through the release of mitochondrial RNA and DNA (mtDNA and mtRNA) fragments into the cytoplasm after infection, activating virus sensors and type-I interferon (IFN-I) response<jats:sup>1–4</jats:sup>. The relevance of these mechanisms for mitochondrial diseases remains understudied. Here we investigated mitochondrial recessive ataxia syndrome (MIRAS), which is caused by a common European founder mutation in DNA polymerase gamma (<jats:italic>POLG1</jats:italic>)<jats:sup>5</jats:sup>. Patients homozygous for the MIRAS variant p.W748S show exceptionally variable ages of onset and symptoms<jats:sup>5</jats:sup>, indicating that unknown modifying factors contribute to disease manifestation. We report that the mtDNA replicase POLG1 has a role in antiviral defence mechanisms to double-stranded DNA and positive-strand RNA virus infections (HSV-1, TBEV and SARS-CoV-2), and its p.W748S variant dampens innate immune responses. Our patient and knock-in mouse data show that p.W748S compromises mtDNA replisome stability, causing mtDNA depletion, aggravated by virus infection. Low mtDNA and mtRNA release into the cytoplasm and a slow IFN response in MIRAS offer viruses an early replicative advantage, leading to an augmented pro-inflammatory response, a subacute loss of GABAergic neurons and liver inflammation and necrosis. A population databank of around 300,000 Finnish individuals<jats:sup>6</jats:sup> demonstrates enrichment of immunodeficient traits in carriers of the <jats:italic>POLG1</jats:italic> p.W748S mutation. Our evidence suggests that POLG1 defects compromise antiviral tolerance, triggering epilepsy and liver disease. The finding has important implications for the mitochondrial disease spectrum, including epilepsy, ataxia and parkinsonism.</jats:p>

    DOI: 10.1038/s41586-024-07260-z

    Scopus

  • Mosaic dysfunction of mitophagy in mitochondrial muscle disease. 査読

    Mito T., Vincent A.E., Faitg J., Taylor R.W., Khan N.A., McWilliams T.G., Suomalainen A.

    Cell Metabolism   34 ( 2 )   197 - 208   2022年2月   ( ISSN:15504131 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Cell Metabolism  

    Mitophagy is a quality control mechanism that eliminates damaged mitochondria, yet its significance in mammalian pathophysiology and aging has remained unclear. Here, we report that mitophagy contributes to mitochondrial dysfunction in skeletal muscle of aged mice and human patients. The early disease stage is characterized by muscle fibers with central nuclei, with enhanced mitophagy around these nuclei. However, progressive mitochondrial dysfunction halts mitophagy and disrupts lysosomal homeostasis. Interestingly, activated or halted mitophagy occur in a mosaic manner even in adjacent muscle fibers, indicating cell-autonomous regulation. Rapamycin restores mitochondrial turnover, indicating mTOR-dependence of mitochondrial recycling in advanced disease stage. Our evidence suggests that (1) mitophagy is a hallmark of age-related mitochondrial pathology in mammalian muscle, (2) mosaic halting of mitophagy is a mechanism explaining mosaic respiratory chain deficiency and accumulation of pathogenic mtDNA variants in adult-onset mitochondrial diseases and normal aging, and (3) augmenting mitophagy is a promising therapeutic approach for muscle mitochondrial dysfunction.

    DOI: 10.1016/j.cmet.2021.12.017

    Scopus

講演・口頭発表等

  • Mosaic Dynamics of Mitophagy in Mitochondrial Disease and Its Contribution to Disease Progression 招待 国際会議

    Takayuki Mito

    The 17th Conference of the Asian Society of Mitochondrial Research and Medicine & the 3rd Conference of Chinese Society of Mitochondrial Research and Medicine  2025年10月 

     詳細を見る

    開催年月日: 2025年10月

    記述言語:英語   会議種別:口頭発表(招待・特別)  

MISC

  • BNIP3/NIX-dependent mitophagy: molecular mechanisms and physiological roles(タイトル和訳中)

    Ginevskaia Tamara, Mito Takayuki, Inoue Keiichi, Kanki Tomotake

    The Journal of Biochemistry   180 ( 3 )   185 - 194   2026年9月   ( ISSN:0021-924X )

     詳細を見る

    記述言語:英語   出版者・発行元:(公社)日本生化学会  

  • BNIP3/NIX-dependent mitophagy: molecular mechanisms and physiological roles 査読 国際誌

    Ginevskaia, T; Mito, T; Inoue, K; Kanki, T

    JOURNAL OF BIOCHEMISTRY   180 ( 3 )   185 - 194   2026年6月   ( ISSN:0021-924X eISSN:1756-2651 )

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:記事・総説・解説・論説等(学術雑誌)  

    Mitochondria are essential for cellular metabolism and homeostasis, and their quality and quantity must therefore be tightly controlled. Mitophagy, a selective form of autophagy targeting mitochondria, contributes to this control by eliminating damaged or superfluous mitochondria. Among the known mitophagy pathways, BNIP3/NIX-dependent mitophagy has emerged as a key mechanism, particularly under hypoxic and metabolic stress. Recent studies have provided important insights into how BNIP3 and NIX are transcriptionally induced, post-translationally regulated, and functionally coupled to the core autophagy machinery. These studies have also clarified their roles in isolation membrane tethering, membrane elongation, and mitophagosome formation. Beyond its molecular basis, accumulating evidence indicates that BNIP3/NIX-dependent mitophagy contributes to mitochondrial homeostasis, redox balance, and cellular stress adaptation. This review summarizes recent progress in understanding the molecular mechanisms and physiological significance of BNIP3/NIX-dependent mitophagy.

    DOI: 10.1093/jb/mvag048

    Web of Science

    PubMed

共同研究・競争的資金等の研究課題

  • マイトファジーが制御する疾患・老化の統合的理解と治療応用

    2026年8月 - 2034年3月

    国立研究開発法人 科学技術振興機構  創発的研究支援事業 

    三藤崇行

      詳細を見る

    担当区分:研究代表者  資金種別:科研費以外の競争的資金

  • マイトファジーによるミトコンドリア病病態形成制御の統合的理解

    研究課題/領域番号:26K02236  2026年4月 - 2029年3月

    科学研究費助成事業  基盤研究(B)

    三藤 崇行, 井上 敬一

      詳細を見る

    担当区分:研究代表者  資金種別:科研費

    ミトコンドリア病の治療標的としてミトコンドリア特異的オートファジー(マイトファジー)が有望視されている。一方、その病態形成への寄与は十分に検証されていない。マイトファジーには複数の独立した分子機構が存在するが、従来は生体内でそれらを特異的に制御することは困難だった。本研究では、ミトコンドリア病モデルマウスとマイトファジー不全マウス群との交配により主要なマイトファジー経路を個別あるいは同時に阻害し、その影響を解析することで、マイトファジーによるミトコンドリア病病態形成制御を統合的に検証する。これにより、ミトコンドリア病に対するマイトファジー標的治療の理論的基盤を確立することを目指す。

    CiNii Research

  • ミトコンドリア病の病態形成における基底マイトファジーの意義の解明

    研究課題/領域番号:25K23827  2025年7月 - 2027年3月

    科学研究費助成事業  研究活動スタート支援

    三藤 崇行

      詳細を見る

    資金種別:科研費

    ミトコンドリアの機能異常によって引き起こされる難病であるミトコンドリア病の治療標的として、マイトファジー(オートファジー機構によるミトコンドリアの選択的分解)が有望視されている。しかし、その治療標的としての妥当性を裏付ける病理学的・病態生理学的な知見は非常に乏しい。本研究では、特定のストレス等の有無にかかわらず恒常的に活性化されているマイトファジー経路(基底マイトファジー)がミトコンドリア病の病態形成に果たす役割を解明することを目的として、ミトコンドリア病モデルマウスにおける基底マイトファジー阻害の影響を解析する。

    CiNii Research